Regulation of the stability and transcriptional activity of NFATc4 by ubiquitination

FEBS Letters

Volumn 582, Issue 29, 2008, Pages 4008-4014

  Fan, Yongna ^a   Xie, Ping ^a   Zhang, Tianpeng ^a   Zhang, Hua ^a   Gu, Dongfeng ^b   She, Mingpeng ^a   Li, Huihua ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b FUWAI HOSPITAL   (China)

Author keywords

Cardiac gene expression; Degradation; Glycogen synthase kinase 3 ; NFATc4; Transcriptional activity; Ubiquitination

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; LYSINE; PROTEASOME; TRANSCRIPTION FACTOR NFAT;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN MODIFICATION; PROTEIN STABILITY; TRANSACTIVATION; UBIQUITINATION;

CALCINEURIN; CELL LINE; CYTOPLASM; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MYOCARDIUM; NFATC TRANSCRIPTION FACTORS; PHOSPHORYLATION; POLYUBIQUITIN; PROTEASOME ENDOPEPTIDASE COMPLEX; TRANSCRIPTION, GENETIC; UBIQUITINATION;

EID: 56949095621     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.11.009     Document Type: Article

References (26)

1. Rao A., Luo C., and Hogan P.G. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15 (1997) 707-747
2. Shaw J.P., Utz P.J., Durand D.B., Toole J.J., Emmel E.A., and Crabtree G.R. Identification of a putative regulator of early T cell activation genes. Science 241 (1988) 202-205
3. Beals C.R., Sheridan C.M., Turck C.W., Gardner P., and Crabtree G.R. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275 (1997) 1930-1934
4. Graef I.A., Mermelstein P.G., Stankunas K., Neilson J.R., Deisseroth K., Tsien R.W., and Crabtree G.R. L-type calcium channels and GSK-3 regulate the activity of NF-ATc4 in hippocampal neurons. Nature 401 (1999) 703-708
5. Pu W.T., Ma Q., and Izumo S. NFAT transcription factors are critical survival factors that inhibit cardiomyocyte apoptosis during phenylephrine stimulation in vitro. Circ. Res. 92 (2003) 725-731
6. van Rooij E., Doevendans P.A., de Theije C.C., Babiker F.A., Molkentin J.D., and de Windt L.J. Requirement of nuclear factor of activated T-cells in calcineurin-mediated cardiomyocyte hypertrophy. J. Biol. Chem. 277 (2002) 48617-48626
7. Wilkins B.J., De Windt L.J., Bueno O.F., Braz J.C., Glascock B.J., Kimball T.F., and Molkentin J.D. Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth. Mol. Cell. Biol. 22 (2002) 7603-7613
8. Crabtree G.R., and Olson E.N. NFAT signaling: choreographing the social lives of cells. Cell 109 Suppl (2002) S67-S79
9. Graef I.A., Chen F., Chen L., Kuo A., and Crabtree G.R. Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. Cell 105 (2001) 863-875
10. Molkentin J.D., Lu J.R., Antos C.L., Markham B., Richardson J., Robbins J., Grant S.R., and Olson E.N. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93 (1998) 215-228
11. Liu C.Z., Tan J.X., Wang Y., Huang Y.G., and Huang D.L. L-type calcium channel blocker suppresses calcineurin signal pathway and development of right ventricular hypertrophy. J. Formos. Med. Assoc. 104 (2005) 798-803
12. Tu V.C., Sun H., Bowden G.T., and Chen Q.M. Involvement of oxidants and AP-1 in angiotensin II-activated NFAT3 transcription factor. Am. J. Physiol. Cell. Physiol. 292 (2007) C1248-C1255
13. Li H.H., Kedar V., Zhang C., McDonough H., Arya R., Wang D.Z., and Patterson C. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J. Clin. Invest. 114 (2004) 1058-1071
14. Li H.H., Willis M.S., Lockyer P., Miller N., McDonough H., Glass D.J., and Patterson C. Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins. J. Clin. Invest. 117 (2007) 3211-3223
15. Pickart C.M., and Raasi S. Controlled synthesis of polyubiquitin chains. Methods Enzymol. 399 (2005) 21-36
16. Raasi S., and Pickart C.M. Ubiquitin chain synthesis. Methods Mol. Biol. 301 (2005) 47-55
17. Pickart C.M., and Fushman D. Polyubiquitin chains: polymeric protein signals. Curr. Opin. Chem. Biol. 8 (2004) 610-616
18. Ito T., Fujio Y., Takahashi K., and Azuma J. Degradation of NFAT5, a transcriptional regulator of osmotic stress-related genes, is a critical event for doxorubicin-induced cytotoxicity in cardiac myocytes. J. Biol. Chem. 282 (2007) 1152-1160
19. Yoeli-Lerner M., Yiu G.K., Rabinovitz I., Erhardt P., Jauliac S., and Toker A. Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol. Cell. 20 (2005) 539-550
20. Tenno T., et al. Structural basis for distinct roles of Lys63- and Lys48-linked polyubiquitin chains. Genes Cells 9 (2004) 865-875
21. Huang H., Regan K.M., Wang F., Wang D., Smith D.I., van Deursen J.M., and Tindall D.J. Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc. Natl. Acad. Sci. USA 102 (2005) 1649-1654
22. Matsuzaki H., Daitoku H., Hatta M., Tanaka K., and Fukamizu A. Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proc. Natl. Acad. Sci. USA 100 (2003) 11285-11290
23. Molkentin J.D. Calcineurin and beyond: cardiac hypertrophic signaling. Circ. Res. 87 (2000) 731-738
24. Heineke J., and Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev. Mol. Cell. Biol. 7 (2006) 589-600
25. Antos C.L., et al. Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo. Proc. Natl. Acad. Sci. USA 99 (2002) 907-912
26. Bourajjaj M., Armand A.S., da Martins P.A., Weijts B., van der Nagel R., Heeneman S., Wehrens X.H., and De Windt L.J. NFATc2 is a necessary mediator of calcineurin-dependent cardiac hypertrophy and heart failure. J. Biol. Chem. 283 (2008) 22295-22303